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To the Editor:
Referring to the article: ‘‘Current practices of driving
restriction implementation for patients with brain tumors’’
by Thomas et al., published in your journal in October
2010 (published online) [1], I am writing to inform readers
of the recent initiative of the Cancer Institute NSW
Oncology Working Group for Neuro-oncology (NSWOG,
Australia) to address the serious issue of driving a motor
vehicle after diagnosis of a brain tumor. Driving a motor
vehicle is a complex task and patients diagnosed with a
brain tumor are at a higher accident risk because of the
significant neurocognitive deficits associated with the dis-
ease. As the authors pointed out, seizures, memory lapses,
and cognitive dysfunction can result from both benign and
malignant brain tumors, placing the driver, its passengers
and innocent bystanders in danger. In the USA, it is up to
individual States to enforce reporting of conditions which
impair driving. In Australia, the driver licensing authority
(DLA) holds the legal responsibility to determine eligibil-
ity to drive, and the treating clinician’s role to provide
relevant medical information [2]. In practice however, the
responsibility lies with the clinician. Australia is fortunate
to have formalized recommendations, but despite the
release of ‘‘Assessing Fitness to Drive’’ by Austroads
(guidelines approved by all Australian licensing authori-
ties), patients are often given conflicting advice with
regards to their ability or fitness to drive. This is consistent
with the findings and conclusions generated by Thomas and
colleagues. In an Australian survey of practicing neuro-
surgeons, neurologists and radiation oncologists (n = 194),
73% of respondents were not aware of any current guide-
lines [3]. Unanimously, the conclusion and recommenda-
tion reached by both the USA and Australian surveys were
to form a multidisciplinary working party to develop more
specific guidelines [1, 3].
In response to these studies, a panel of experts in neu-
rosurgery, medical oncology, occupational therapy, reha-
bilitation and allied nursing staff generated two
information brochures- one for clinicians and another
designed for patients. The Brain Tumors and Driving: A
guide for Clinicians brochure highlights a simplified
algorithm to help the clinician provide informed advice in
regard to driving a motor vehicle to their patients. The
algorithm begins with confirmed diagnosis of a brain
tumor. The next step of the algorithm decision tree pertains
to treatment and physiology: Has the patient had a crani-
otomy? If this is the case, it is an Australian recommen-
dation to not drive for 3 months. After the 3 months, the
algorithm addresses the presentation of significant deficits,
borderline deficits or no deficits? In the presence of a
significant deficit, no driving is permitted. In the case of a
borderline deficit, referral to an occupation therapist is
recommended and fitness to drive assessed. For patients
with no deficit, the green light is given for driving. This
algorithm does not discriminate between benign and
malignant tumors since seizure activity is independent of
grade. The algorithm is predominantly based on deficit
presentation. Guidelines for seizures are also presented.
Quite often, conflict can occur between the patient and
clinician delivering the news that they are not fit to drive.
The brochure for clinicians provides useful information in
regard to how to talk to patients and their families and tips
about licence reinstatement and help lines. In addition, the
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NSWOG working group developed a second brochure to
give to patients. The Brain Tumors and Driving: A guide for
patients and carers outlines in layman’s terms the reasons why
they should not be driving, what the responsibilities of the
clinician are, what the process is for returning to driving and a
list of alternatives in the case where the patient cannot drive.
Driving is a privilege, not a right and driving by people with
brain tumors is a serious issue. The two Brain Tumor and
Driving Brochures can be found at http://www.cancerinstitute.
org.au/cancer_inst/nswog/groups/neuro1.html.
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